LNTH

Health Care Sector Update for 01/26/2024: LNTH, PTCT, PCSA

Health care stocks were advancing Friday afternoon, with the NYSE Health Care Index rising 0.8% and the Health Care Select Sector SPDR Fund (XLV) up 0.6%.

The iShares Biotechnology ETF (IBB) was fractionally lower.

In corporate news, Lantheus (LNTH) said Friday it's being sued by two Novartis (NVS) entities for patent infringement in connection to a generic drug used to treat certain neuroendocrine tumors. Lantheus shares were rising 1.5%.

PTC Therapeutics (PTCT) shed 0.3% after saying the European Medicines Agency's Committee for Medicinal Products for Human Use issued a negative opinion following a re-examination procedure for the conditional marketing authorization of Translarna.

Processa Pharmaceuticals (PCSA) said Friday it priced a public offering of 1.6 million shares and warrants to buy up to 1.6 million of its common stock for gross proceeds of about $7 million. Its shares sank 29%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.